Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol
Autor: | Yutaka Ueda, Masaaki Inoue, Nobuhisa Ishikawa, Hideto Obata, Masahiro Kodani, Shoichi Kuyama, Kazuya Nishii, Takuo Shibayama, Katsuyuki Hotta, Tetsuya Kubota, Tomoya Ishii, Kazunori Fujitaka, Hirohisa Ichikawa, Nobukazu Fujimoto, Masahiro Yamasaki, Yukari Tsubata, Daizo Kishino, Yoshikazu Awaya, Toshiyuki Kozuki, Tomonori Moritaka, Keisuke Sugimoto, Kenichi Gemba, Katsuyuki Kiura |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Male
0301 basic medicine Pulmonary and Respiratory Medicine medicine.medical_specialty Lung Neoplasms Disease lcsh:RC254-282 Database Study Protocol 03 medical and health sciences 0302 clinical medicine medicine Clinical endpoint Humans Prospective Studies Registries Intensive care medicine Lung cancer Protocol (science) treatment business.industry Cancer General Medicine Patient registration medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Cancer registry real world data 030104 developmental biology Oncology 030220 oncology & carcinogenesis surveillance Female Observational study observational study business |
Zdroj: | Thoracic Cancer, Vol 12, Iss 5, Pp 725-731 (2021) Thoracic Cancer |
ISSN: | 1759-7706 1759-7714 |
Popis: | Introduction Conventional cancer registries are suitable for simple surveillance of cancer patients, including disease frequency and distribution, demographics, and prognosis; however, the collected data are inadequate to clarify comprehensively diverse clinical questions in daily practice. Methods We constructed an umbrella‐type lung cancer patient registry (CS‐Lung‐003) integrating multiple related prospective observational studies (linked studies) that reflect clinical questions about lung cancer treatment. The primary endpoint of this registry is to clarify daily clinical practice patterns in lung cancer treatment; a key inclusion criterion is pathologically diagnosed lung cancer. Under this registry, indispensable clinical items are detected in advance across all active linked studies and gathered prospectively and systematically to avoid excessive or insufficient data collection. Researchers are to input information mutually, irrespective of the relevance to each researcher's own study. Linked studies under the umbrella of the CS‐Lung‐003 registry will be updated annually with newly raised clinical questions; some linked studies will be newly created, while others will be deleted after the completion of the analysis. Enrollment began in July 2017. Discussion We successfully launched the umbrella‐type CS‐Lung‐003 registry. Under this single registry, researchers collaborate on patient registration and data provision for their own and other studies. Thus, the registry will produce results for multiple domains of study, providing answers to questions about lung cancer treatment raised by other researchers. Through such analysis of each linked study, this registry will contribute to the comprehensive elucidation of actual daily practice patterns in lung cancer treatment. Key points CS‐Lung‐003 registry directly integrates multiple linked studies created under the umbrella of this cancer registry to solve various clinical questions regarding daily practice patterns of lung cancer treatment. We constructed an umbrella‐type lung cancer patient registry (CS‐Lung‐003) integrating multiple related prospective observational studies (linked studies) that reflect clinical questions about lung cancer treatment. Under this single registry, researchers collaborate on patient registration and data provision for their own and other studies. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |